Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial

被引：27
|
作者：
Spaner, David E. [1 ,2 ,3 ,4 ,5 ]
Wang, Guizhei [1 ]
McCaw, Lindsay [1 ]
Li, Yanmei [1 ]
Disperati, Patricia [6 ]
Cussen, Mary-Ann [3 ]
Shi, Yonghong [1 ]
机构：
[1] Sunnybrook Res Inst, Biol Platform, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada
[3] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada
[6] Toronto East Gen Hosp, Toronto, ON, Canada
来源：
HAEMATOLOGICA | 2016年 / 101卷 / 05期
关键词：
chronic lymphocytic leukemia; Janus Kinases; STAT3; Ruxolitinib; Ibrutinib; Kinase inhibitors; phosphoproteome; FOLLOW-UP; RESISTANCE; THERAPY; CELLS; CLL;
D O I：
10.3324/haematol.2015.135418
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Duvelisib: a phosphoinositide-3 kinase/inhibitor for chronic lymphocytic leukemia
    Vangapandu, Hima V.
    Jain, Nitin
    Gandhi, Varsha
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (05) : 625 - 632
  • [32] Efficacy and safety of topical janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis: Results of a phase IIA randomized clinical trial
    Ports, William
    Bolduc, Chantal
    Papp, Kim
    Lamba, Manisha
    Bissonnette, Robert
    Khan, Shahbaz
    Lan, Shuping
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB199 - AB199
  • [33] SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naive Patients With Myelofibrosis
    Mesa, Ruben A.
    Kiladjian, Jean-Jacques
    Catalano, John V.
    Devos, Timothy
    Egyed, Miklos
    Hellmann, Andrzei
    McLornan, Donal
    Shimoda, Kazuya
    Winton, Elliott F.
    Deng, Wei
    Dubowy, Ronald L.
    Maltzman, Julia D.
    Cervantes, Francisco
    Gotlib, Jason
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3844 - +
  • [34] The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
    Alessandro Gozzetti
    Enrico Capochiani
    Monica Bocchia
    Leukemia, 2020, 34 : 2815 - 2816
  • [35] The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
    Gozzetti, Alessandro
    Capochiani, Enrico
    Bocchia, Monica
    LEUKEMIA, 2020, 34 (10) : 2815 - 2816
  • [36] Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
    Fischer, Kirsten
    Cramer, Paula
    Busch, Raymonde
    Boettcher, Sebastian
    Bahlo, Jasmin
    Schubert, Joeerg
    Pflueger, Karl H.
    Schott, Silke
    Goede, Valentin
    Isfort, Susanne
    von Tresckow, Julia
    Fink, Anna-Maria
    Buehler, Andreas
    Winkler, Dirk
    Kreuzer, Karl-Anton
    Staib, Peter
    Ritgen, Matthias
    Kneba, Michael
    Doehner, Hartmut
    Eichhorst, Barbara F.
    Hallek, Michael
    Stilgenbauer, Stephan
    Wendtner, Clemens-Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3209 - 3216
  • [37] Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
    Fischer, Kirsten
    Cramer, Paula
    Busch, Raymonde
    Stilgenbauer, Stephan
    Bahlo, Jasmin
    Schweighofer, Carmen D.
    Boettcher, Sebastian
    Staib, Peter
    Kiehl, Michael
    Eckart, Michael J.
    Kranz, Gabriele
    Goede, Valentin
    Elter, Thomas
    Buehler, Andreas
    Winkler, Dirk
    Kneba, Michael
    Doehner, Hartmut
    Eichhorst, Barbara F.
    Hallek, Michael
    Wendtner, Clemens-Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3559 - 3566
  • [38] Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
    Friedman, Daphne R.
    Davis, Patricia H.
    Lanasa, Mark C.
    Moore, Joseph O.
    Gockerman, Jon P.
    Nelson, Taylor
    Bond, Karen M.
    Jiang, Ning
    Davis, Evan D.
    Allgood, Sallie D.
    Chen, Youwei
    Sportelli, Peter
    Weinberg, J. Brice
    BLOOD, 2010, 116 (21) : 768 - 769
  • [39] Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial
    Gore, Lia
    Kearns, Pamela R.
    de Martino Lee, Maria Lucia
    De Souza, Carmino Antonio
    Bertrand, Yves
    Hijiya, Nobuko
    Stork, Linda C.
    Chung, Nack-Gyun
    Cardos, Rocio Cardenas
    Saikia, Tapan
    Fagioli, Franca
    Seo, Jong Jin
    Landman-Parker, Judith
    Lancaster, Donna
    Place, Andrew E.
    Rabin, Karen R.
    Sacchi, Mariana
    Swanink, Rene
    Zwaan, C. Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (13) : 1330 - +
  • [40] PENTOSTATIN IN CHRONIC LYMPHOCYTIC-LEUKEMIA - A PHASE-II TRIAL OF CANCER AND LEUKEMIA GROUP-B
    DILLMAN, RO
    MICK, R
    MCINTYRE, OR
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 433 - 438
12345